Dipal Doshi - CEO, Director at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dipal Doshi since 12 Feb 2025

Holdings reported by Dipal Doshi for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 415,664 $2,257,138 $5.43 02 Sep 2025 Direct
Stock Option (Right to Buy) 173,400 01 Mar 2025 Direct Common Stock

Transactions reported by Dipal Doshi for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.